MDT · Medtronic plc

Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,863 shares will be issued. If maximum performance metrics are achieved, 38,071 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 23,074 shares will be issued. If maximum performance metrics are achieved, 55,378 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Represents restricted stock units that vest in four annual installments beginning one year from the date of grant.

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 17,306 shares will be issued. If maximum performance metrics are achieved, 41,534 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 28,842 shares will be issued. If maximum performance metrics are achieved, 69,221 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 2,337 shares will be issued. If maximum performance metrics are achieved, 5,609 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 103,831 shares will be issued. If maximum performance metrics are achieved, 249,194 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 27,400 shares will be issued. If maximum performance metrics are achieved, 65,760 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

Includes 534 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 14,421 shares will be issued. If maximum performance metrics are achieved, 34,610 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

Includes 136 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

Includes 140 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

Includes 547 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

Includes 980 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

Includes 188 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

Includes 286 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

Includes 697 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Includes 107 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person.

Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on April 24, 2026.

Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on April 24, 2026.

Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on April 24, 2026.

Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on April 24, 2026.

Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on April 24, 2026.

Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026.

Includes 527 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026.

Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026.

Includes 781 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026.

Includes 1,743 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026.

Includes 270 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

The performance share units vested on April 24, 2026.

Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026, of which 1,027 shares will be delivered to the reporting person when her employment with the Company ends.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

The performance share units vested on April 24, 2026.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

The performance share units vested on April 24, 2026.